| Year |
Citation |
Score |
| 2022 |
Kumar V, Sethi B, Yanez E, Leung DH, Ghanwatkar YY, Cheong J, Tso J, Narang AS, Nagapudi K, Mahato RI. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate. International Journal of Pharmaceutics. 615: 121470. PMID 35041913 DOI: 10.1016/j.ijpharm.2022.121470 |
0.508 |
|
| 2021 |
Chen Y, Lubach JW, Tang S, Narang AS. Effect of Counterions on Dissolution of Amorphous Solid Dispersions Studied by Surface Area Normalized Dissolution. Molecular Pharmaceutics. PMID 34338529 DOI: 10.1021/acs.molpharmaceut.1c00325 |
0.338 |
|
| 2020 |
Kumar V, Bariwal J, Narang AS, Tso J, Cheong J, Mahato RI. Functional similarity of modified cascade impactor to deposit drug particles on cells. International Journal of Pharmaceutics. 119404. PMID 32387312 DOI: 10.1016/J.Ijpharm.2020.119404 |
0.531 |
|
| 2019 |
Puri V, Shur J, Narang AS. Elucidating Molecular- and Particle-Level Changes during the Annealing of a Micronized Crystalline Drug. Molecular Pharmaceutics. PMID 31454254 DOI: 10.1021/acs.molpharmaceut.9b00692 |
0.336 |
|
| 2018 |
Kaur N, Narang A, Kumar Bansal A. Use of Biorelevant Dissolution and PBPK Modeling to Predict Oral Drug Absorption. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. PMID 29879527 DOI: 10.1016/j.ejpb.2018.05.024 |
0.34 |
|
| 2015 |
Mantri RV, Wu Y, Levons JK, Narang AS, Raghavan K. Reactive impurities in excipients Excipient Applications in Formulation Design and Drug Delivery. 37-65. DOI: 10.1007/978-3-319-20206-8_3 |
0.312 |
|
| 2015 |
Narang AS, Boddu SH. Excipient applications in formulation design and drug delivery Excipient Applications in Formulation Design and Drug Delivery. 1-681. DOI: 10.1007/978-3-319-20206-8 |
0.3 |
|
| 2012 |
Narang AS, Desai D, Badawy S. Physicochemical interactions in solid dosage forms. Pharmaceutical Research. 29: 2635-8. PMID 22936283 DOI: 10.1007/s11095-012-0867-5 |
0.307 |
|
| 2012 |
Narang AS, Desai D, Badawy S. Impact of excipient interactions on solid dosage form stability. Pharmaceutical Research. 29: 2660-83. PMID 22707362 DOI: 10.1007/s11095-012-0782-9 |
0.342 |
|
| 2012 |
Panakanti R, Narang AS. Impact of excipient interactions on drug bioavailability from solid dosage forms. Pharmaceutical Research. 29: 2639-59. PMID 22610283 DOI: 10.1007/S11095-012-0767-8 |
0.582 |
|
| 2012 |
Narang AS, Yamniuk AP, Zhang L, Comezoglu SN, Bindra DS, Varia S, Doyle ML, Badawy S. Reversible and pH-dependent weak drug-excipient binding does not affect oral bioavailability of high dose drugs. The Journal of Pharmacy and Pharmacology. 64: 553-65. PMID 22420661 DOI: 10.1111/j.2042-7158.2011.01435.x |
0.343 |
|
| 2011 |
Singh S, Narang AS, Mahato RI. Subcellular fate and off-target effects of siRNA, shRNA, and miRNA. Pharmaceutical Research. 28: 2996-3015. PMID 22033880 DOI: 10.1007/S11095-011-0608-1 |
0.476 |
|
| 2011 |
Wu Y, Levons J, Narang AS, Raghavan K, Rao VM. Reactive impurities in excipients: profiling, identification and mitigation of drug-excipient incompatibility. Aaps Pharmscitech. 12: 1248-63. PMID 21948318 DOI: 10.1208/s12249-011-9677-z |
0.326 |
|
| 2007 |
Narang AS, Delmarre D, Gao D. Stable drug encapsulation in micelles and microemulsions. International Journal of Pharmaceutics. 345: 9-25. PMID 17945446 DOI: 10.1016/j.ijpharm.2007.08.057 |
0.361 |
|
| 2006 |
Narang AS, Sabek O, Gaber AO, Mahato RI. Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharmaceutical Research. 23: 1970-82. PMID 16906455 DOI: 10.1007/s11095-006-9065-7 |
0.499 |
|
| 2006 |
Narang AS, Mahato RI. Biological and biomaterial approaches for improved islet transplantation. Pharmacological Reviews. 58: 194-243. PMID 16714486 DOI: 10.1124/Pr.58.2.6 |
0.514 |
|
| 2005 |
Narang AS, Thoma L, Miller DD, Mahato RI. Cationic lipids with increased DNA binding affinity for nonviral gene transfer in dividing and nondividing cells. Bioconjugate Chemistry. 16: 156-68. PMID 15656587 DOI: 10.1021/Bc049818Q |
0.521 |
|
| 2004 |
Narang AS, Cheng K, Henry J, Zhang C, Sabek O, Fraga D, Kotb M, Gaber AO, Mahato RI. Vascular endothelial growth factor gene delivery for revascularization in transplanted human islets. Pharmaceutical Research. 21: 15-25. PMID 14984253 DOI: 10.1023/B:Pham.0000012147.52900.B8 |
0.535 |
|
| 2003 |
Mahato RI, Narang AS, Thoma L, Miller DD. Emerging trends in oral delivery of peptide and protein drugs. Critical Reviews in Therapeutic Drug Carrier Systems. 20: 153-214. PMID 14584523 DOI: 10.1615/Critrevtherdrugcarriersyst.V20.I23.30 |
0.567 |
|
| 2003 |
Mahato RI, Henry J, Narang AS, Sabek O, Fraga D, Kotb M, Gaber AO. Cationic lipid and polymer-based gene delivery to human pancreatic islets. Molecular Therapy : the Journal of the American Society of Gene Therapy. 7: 89-100. PMID 12573622 DOI: 10.1016/S1525-0016(02)00031-X |
0.551 |
|
| 2002 |
Wang DA, Narang AS, Kotb M, Gaber AO, Miller DD, Kim SW, Mahato RI. Novel branched poly(ethylenimine)-cholesterol water-soluble lipopolymers for gene delivery. Biomacromolecules. 3: 1197-207. PMID 12425656 DOI: 10.1021/Bm025563C |
0.527 |
|
| 2002 |
Narang AS, Srivastava AK. Evaluation of solid dispersions of Clofazimine. Drug Development and Industrial Pharmacy. 28: 1001-13. PMID 12378955 DOI: 10.1081/DDC-120006431 |
0.343 |
|
| Show low-probability matches. |